Varlitinib Mediates Its Activity Through Down Regulating MAPK/EGFR Pathway in Oral Cancer
作者: Muhammad UsmanFariha TanveerAmber IlyasShamshad Zarina
刊名: Current Proteomics, 2019, Vol.17 (1), pp.51-58
来源数据库: Bentham Journal
DOI: 10.2174/1570164616666190516114749
关键词: Oral carcinomaSignal transductionEGFR pathwaySCC-25 OSCC cell linesVarlitinibTobacco.
原始语种摘要: Background: Oral squamous cell carcinoma (OSCC) is a major sub-type of oral cancer that shares 90% proportion of oral cavity cancers. It is declared as sixth most frequent cancer among all cancer types throughout the world. Higher morbidity in Asian countries is reported due to frequent use of smokeless tobacco (SLT) products besides exposure to other risk factors. Hyper-activation of epidermal growth factor receptors is a molecular event in many solid tumors including oral cancer making them potential therapeutic targets.Objective: Current study was designed to explore the effect of varlitinib, a pan-HER inhibitor, on oral cancer cell line. We investigated key regulatory genes in downstream pathway in response to drug treatment. Furthermore, we also examined expression profile of these...
全文获取路径: PDF下载  Bentham  (合作)
分享到:
来源刊物:
影响因子:0.828 (2012)

×
关键词翻译
关键词翻译
  • potential 
  • carcinoma 癌症
  • therapeutic 治疗的
  • untreated 未处理的
  • Cancer 巨蟹座
  • cancer 癌症
  • carcinogenesis 癌形成
  • squamous 具鳞的
  • combined 组合
  • expression 表示